Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,233 | 549 | 93.1% |
| Honoraria | $450.00 | 1 | 4.1% |
| Education | $309.72 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,133 | 116 | $0 (2024) |
| Janssen Biotech, Inc. | $1,103 | 74 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $959.40 | 38 | $0 (2024) |
| LEO Pharma Inc. | $718.64 | 30 | $0 (2024) |
| Galderma Laboratories, L.P. | $593.35 | 31 | $0 (2023) |
| Biofrontera Inc. | $591.21 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $525.07 | 26 | $0 (2024) |
| MAYNE PHARMA INC. | $422.46 | 49 | $0 (2022) |
| Amgen Inc. | $408.35 | 22 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $366.86 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,434 | 79 | Regeneron Healthcare Solutions, Inc. ($320.37) |
| 2023 | $2,262 | 94 | AbbVie Inc. ($662.00) |
| 2022 | $1,406 | 69 | Regeneron Healthcare Solutions, Inc. ($315.86) |
| 2021 | $900.47 | 46 | AbbVie Inc. ($314.52) |
| 2020 | $1,197 | 69 | AbbVie Inc. ($359.79) |
| 2019 | $1,182 | 65 | Galderma Laboratories, L.P. ($275.35) |
| 2018 | $751.48 | 55 | Galderma Laboratories, L.P. ($146.48) |
| 2017 | $1,859 | 79 | Biofrontera Inc. ($450.00) |
All Payment Transactions
556 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,236 | 12,607 | $1.2M | $398,860 |
| 2022 | 37 | 4,151 | 12,270 | $1.2M | $369,645 |
| 2021 | 40 | 4,341 | 9,277 | $1.3M | $412,802 |
| 2020 | 37 | 4,370 | 14,026 | $1.2M | $384,160 |
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 844 | 1,154 | $212,559 | $63,758 | 30.0% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 103 | 114 | $150,359 | $48,564 | 32.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 507 | 654 | $144,355 | $48,146 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 425 | 558 | $138,650 | $45,409 | 32.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 708 | 932 | $121,663 | $32,325 | 26.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 140 | 221 | $76,257 | $26,933 | 35.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 581 | 3,914 | $53,446 | $18,787 | 35.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 29 | 39 | $31,246 | $12,018 | 38.5% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 116 | 151 | $29,971 | $12,004 | 40.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 17 | 17 | $25,391 | $10,019 | 39.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 103 | 108 | $26,431 | $9,445 | 35.7% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 48 | 49 | $45,073 | $9,311 | 20.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 29 | $17,157 | $6,302 | 36.7% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 14 | 4,000 | $7,200 | $4,927 | 68.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 40 | $14,611 | $4,655 | 31.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 71 | 74 | $14,625 | $4,488 | 30.7% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 14 | 21 | $11,459 | $4,206 | 36.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 38 | 45 | $12,981 | $4,172 | 32.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 97 | 105 | $11,520 | $4,102 | 35.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $13,704 | $4,075 | 29.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 12 | 13 | $7,989 | $2,866 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,098 | $2,763 | 34.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 27 | 29 | $7,489 | $2,564 | 34.2% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 19 | 20 | $6,499 | $2,301 | 35.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 16 | 18 | $6,600 | $2,265 | 34.3% |
About Dr. Amy Brackeen, MD
Dr. Amy Brackeen, MD is a MOHS-Micrographic Surgery healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427036417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Brackeen, MD has received a total of $10,993 in payments from pharmaceutical and medical device companies, with $1,434 received in 2024. These payments were reported across 556 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,233).
As a Medicare-enrolled provider, Brackeen has provided services to 17,098 Medicare beneficiaries, totaling 48,180 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Lubbock, TX
- Active Since 01/09/2006
- Last Updated 09/15/2022
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1427036417
Products in Payments
- TREMFYA (Drug) $867.03
- SKYRIZI (Biological) $763.63
- DUPIXENT (Biological) $729.09
- ADBRY (Biological) $558.03
- AMELUZ (Drug) $521.44
- BOTOX (Biological) $484.53
- Otezla (Drug) $453.30
- DORYX (Drug) $403.77
- Sotyktu (Drug) $400.60
- RINVOQ (Biological) $370.81
- EUCRISA (Drug) $353.46
- COSENTYX (Biological) $319.12
- STELARA (Biological) $302.30
- HUMIRA (Biological) $267.12
- Humira (Biological) $247.24
- ILUMYA (Biological) $208.77
- Tremfya (Drug) $188.38
- LIBTAYO (Biological) $178.08
- Erivedge (Biological) $171.01
- EPIDUO FORTE (Drug) $153.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Lubbock
Jeffrey Brackeen, M.d, M.D
MOHS-Micrographic Surgery — Payments: $13,594
Dr. Brent Paulger, M.d, M.D
MOHS-Micrographic Surgery — Payments: $7,217
Dr. Michael Long, M.d, M.D
MOHS-Micrographic Surgery — Payments: $5,323